Статті в журналах з теми "Group 2 influenza A"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Group 2 influenza A".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Friesen, R. H. E., P. S. Lee, E. J. M. Stoop, R. M. B. Hoffman, D. C. Ekiert, G. Bhabha, W. Yu, et al. "A common solution to group 2 influenza virus neutralization." Proceedings of the National Academy of Sciences 111, no. 1 (December 11, 2013): 445–50. http://dx.doi.org/10.1073/pnas.1319058110.
Повний текст джерелаJoyce, M. Gordon, Adam K. Wheatley, Paul V. Thomas, Gwo-Yu Chuang, Cinque Soto, Robert T. Bailer, Aliaksandr Druz, et al. "Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses." Cell 166, no. 3 (July 2016): 609–23. http://dx.doi.org/10.1016/j.cell.2016.06.043.
Повний текст джерелаEkiert, D. C., R. H. E. Friesen, G. Bhabha, T. Kwaks, M. Jongeneelen, W. Yu, C. Ophorst, et al. "A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses." Science 333, no. 6044 (July 7, 2011): 843–50. http://dx.doi.org/10.1126/science.1204839.
Повний текст джерелаLahad, Amnon. "Small-group consensus process promoted influenza practice guidelines acceptance." ACP Journal Club 123, no. 2 (September 1, 1995): 55. http://dx.doi.org/10.7326/acpjc-1995-123-2-055.
Повний текст джерелаDu, Ruikun, Han Cheng, Qinghua Cui, Norton P. Peet, Irina N. Gaisina, and Lijun Rong. "Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins." Antiviral Research 186 (February 2021): 105013. http://dx.doi.org/10.1016/j.antiviral.2021.105013.
Повний текст джерелаEnde, Zachary S., Margarita Mishina, Robert Kauffman, Zhu Guo, Zhunan Li, Weiping Cao, Sean Ray, et al. "Expression and characterization of a monoclonal IgA isotype antibody against group 1 and group 2 influenza of the HV1-18 QxxV class." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 93.23. http://dx.doi.org/10.4049/jimmunol.204.supp.93.23.
Повний текст джерелаLiu, Lu, Raffael Nachbagauer, Lingyan Zhu, Yang Huang, Xinci Xie, Shan Jin, Anli Zhang, et al. "Natural H7N9 infection in humans boosts cross-group stalk-specific antibody responses broadly cross-reactive to heterosubtypic influenza hemagglutinins from both group 1 and group 2." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 125.18. http://dx.doi.org/10.4049/jimmunol.198.supp.125.18.
Повний текст джерелаWu, Yan, Feng Gao, Jianxun Qi, Yuhai Bi, Lifeng Fu, Sankar Mohan, Yuhang Chen, et al. "Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor." Journal of Virology 90, no. 23 (September 21, 2016): 10693–700. http://dx.doi.org/10.1128/jvi.01703-16.
Повний текст джерелаMargine, I., F. Krammer, R. Hai, N. S. Heaton, G. S. Tan, S. A. Andrews, J. A. Runstadler, et al. "Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses." Journal of Virology 87, no. 19 (July 31, 2013): 10435–46. http://dx.doi.org/10.1128/jvi.01715-13.
Повний текст джерелаCorti, D., J. Voss, S. J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S. G. Vachieri, et al. "A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins." Science 333, no. 6044 (July 28, 2011): 850–56. http://dx.doi.org/10.1126/science.1205669.
Повний текст джерелаMarjuki, Henju, Vasiliy P. Mishin, Ning Chai, Man-Wah Tan, Elizabeth M. Newton, John Tegeris, Karl Erlandson, et al. "Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins." Journal of Virology 90, no. 23 (September 14, 2016): 10446–58. http://dx.doi.org/10.1128/jvi.01284-16.
Повний текст джерелаHussain, Hamid. "Trends, patterns, and incidence rate of seasonal influenza among Dubai population and some associated factors, 2017-2-19." International Journal of Clinical Case Reports and Reviews 7, no. 1 (April 13, 2021): 01–06. http://dx.doi.org/10.31579/2690-4861/109.
Повний текст джерелаD’Souza, Shanti, Xiaofei Shen, Ivan T. H. Fung, Longyun Ye, Marcy Kuentzel, Sridar V. Chittur, Yoichi Furuya, et al. "Compartmentalized effects of aging on group 2 innate lymphoid cell development and function." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 234.8. http://dx.doi.org/10.4049/jimmunol.204.supp.234.8.
Повний текст джерелаSei, Clara J., Nimisha Rikhi, Rachmat Hidajat, Richard F. Schuman, Kevin Muema, Jasmine M. Mutunga, Luke T. Daum, and Gerald W. Fischer. "2752. Peptide Vaccines Utilizing Conserved Hemagglutinin, Neuraminidase, and Matrix Ectodomain Influenza Epitopes Demonstrate Functional Activity Against Group 1 and 2 Influenza Strains." Open Forum Infectious Diseases 6, Supplement_2 (October 2019): S969—S970. http://dx.doi.org/10.1093/ofid/ofz360.2429.
Повний текст джерелаChao, Chien-Ming, Chih-Cheng Lai, Hsuan-Fu Ou, Chung-Han Ho, Khee-Siang Chan, Chun-Chieh Yang, Chin-Ming Chen, and Wen-Liang Yu. "The Impacts of Aspergillosis on Outcome, Burden and Risks for Mortality in Influenza Patients with Critical Illness." Journal of Fungi 7, no. 11 (October 29, 2021): 922. http://dx.doi.org/10.3390/jof7110922.
Повний текст джерелаÖztelcan Gündüz, Bahar, Erman Ataş, Bülent Ünay, and Halit Halil. "Evaluation of Influenza Patients Admitted in 2019–2020 Flu Season." Journal of Pediatric Infectious Diseases 17, no. 02 (January 3, 2022): 076–82. http://dx.doi.org/10.1055/s-0041-1741003.
Повний текст джерелаNikolaeva, S. V., Yu N. Khlypovka, E. K. Shushakova, N. A. Meshkova, D. A. Khavkina, P. V. Chukhliaev, and T. A. Ruzhentsova. "Features of influenza’s course in combination with other viruses in children." Medical alphabet, no. 32 (December 16, 2021): 7–9. http://dx.doi.org/10.33667/2078-5631-2021-32-7-9.
Повний текст джерелаMatsumoto, Kazuhiro, Wakaba Fukushima, Saeko Morikawa, Masashi Fujioka, Tohru Matsushita, Megumi Kubota, Yoshina Yagi, et al. "Influence of Prior Influenza Vaccination on Current Influenza Vaccine Effectiveness in Children Aged 1 to 5 Years." Vaccines 9, no. 12 (December 7, 2021): 1447. http://dx.doi.org/10.3390/vaccines9121447.
Повний текст джерелаZhirnov, O. P., N. O. Bokova, E. I. Isaeva, I. V. Vorobeva, T. E. Konakova, and N. A. Malyshev. "Therapeutic effect of aerosol form of aprotinin against Influenza." Epidemiology and Infectious Diseases 19, no. 6 (December 15, 2014): 10–15. http://dx.doi.org/10.17816/eid40817.
Повний текст джерелаEditorial, Article. "Influenza and ARVI: challenges and solutions." Medical Council, no. 2 (February 16, 2019): 68–75. http://dx.doi.org/10.21518/2079-701x-2019-2-68-75.
Повний текст джерелаChioato, A., E. Noseda, S. D. Felix, M. Stevens, G. Del Giudice, S. Fitoussi та A. Kleinschmidt. "Influenza and Meningococcal Vaccinations Are Effective in Healthy Subjects Treated with the Interleukin-1β-Blocking Antibody Canakinumab: Results of an Open-Label, Parallel Group, Randomized, Single-Center Study". Clinical and Vaccine Immunology 17, № 12 (20 жовтня 2010): 1952–57. http://dx.doi.org/10.1128/cvi.00175-10.
Повний текст джерелаDhumad, Bushra Qasim, and Safa Ibrahim Jaber. "Mutation Occurrence in Tor2 Gene in Patients with SARS COV-2 in Association with H. Influenza Infection." Biomedical and Pharmacology Journal 15, no. 1 (March 31, 2022): 305–12. http://dx.doi.org/10.13005/bpj/2368.
Повний текст джерелаMcCarthy, Kevin R., Akiko Watanabe, Masayuki Kuraoka, Khoi T. Do, Charles E. McGee, Gregory D. Sempowski, Thomas B. Kepler, Aaron G. Schmidt, Garnett Kelsoe, and Stephen C. Harrison. "Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires." Immunity 48, no. 1 (January 2018): 174–84. http://dx.doi.org/10.1016/j.immuni.2017.12.009.
Повний текст джерелаKumar, P., R. Trebbien, P. C. Leutscher, L. Strandbygaard, and C. Rasmussen. "FRI0525 INFLUENZA VACCINATION COMPLIANCE AND RESPONSE IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASE PATIENTS: A COHORT STUDY." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 862.1–862. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1754.
Повний текст джерелаZhdanov, K. V., R. F. Khamitov, V. V. Rafalsky, M. P. Mikhaylusova, Yu S. Shapovalova, R. A. Oseshnyuk та D. N. Alpenidze. "The use of antiviral drug based on technologically processed antibodies to interferon-γ, CD4 receptor and histamine in the treatment of influenza in adults: results of a multicenter open-label randomized comparative trial with oseltamivir". Infekcionnye bolezni 19, № 1 (2021): 39–57. http://dx.doi.org/10.20953/1729-9225-2021-1-39-57.
Повний текст джерелаSzilagyi, Peter G., Stanley Schaffer, Cynthia M. Rand, Nicolas P. N. Goldstein, Mary Younge, Michael Mendoza, Christina S. Albertin, et al. "Text Message Reminders for Child Influenza Vaccination in the Setting of School-Located Influenza Vaccination: A Randomized Clinical Trial." Clinical Pediatrics 58, no. 4 (January 2, 2019): 428–36. http://dx.doi.org/10.1177/0009922818821878.
Повний текст джерелаMORISHITA, T., E. NOBUSAWA, S. LUO, K. SATO, S. NAKAJIMA, and K. NAKAJIMA. "Analysis of the host-specific haemagglutination of influenza A(H1N1) viruses isolated in the 1995/6 season." Epidemiology and Infection 119, no. 3 (December 1997): 327–34. http://dx.doi.org/10.1017/s0950268897008248.
Повний текст джерелаNishimura, Hidekazu, Akira Suzuki, Oshi Watanabe, Kikuyoshi Yoshida, Kazuo Akiyama, Yoshio Koyanagi, Yasuhiko Hayakawa, Shigeki Moriizumi, and Katumi Mizuta. "An attempt of a pandemic planning by a local group for 2 years: the Miyagi Pandemic Influenza Study Group in Sendai, Japan." International Congress Series 1263 (June 2004): 818–21. http://dx.doi.org/10.1016/j.ics.2004.01.026.
Повний текст джерелаReemers, Sylvia, Denny Sonnemans, Linda Horspool, Sander van Bommel, Qi Cao, and Saskia van de Zande. "Determining Equine Influenza Virus Vaccine Efficacy—The Specific Contribution of Strain Versus Other Vaccine Attributes." Vaccines 8, no. 3 (September 3, 2020): 501. http://dx.doi.org/10.3390/vaccines8030501.
Повний текст джерелаZheng, Jing-Quan, Cheng-Hsin Lin, Chun-Chao Chen, Yuan-Feng Lin, Chun-Chih Chiu, Tsung Yeh Yang, Min-Huei Hsu, et al. "Role of Annual Influenza Vaccination against Lung Cancer in Type 2 Diabetic Patients from a Population-Based Cohort Study." Journal of Clinical Medicine 10, no. 15 (August 1, 2021): 3434. http://dx.doi.org/10.3390/jcm10153434.
Повний текст джерелаTharu, Bhikhari P. "The average peak time and intensity of seasonal influenza may vary by age: a study of laboratory confirmed influenza." Journal of Infection Prevention 21, no. 5 (June 10, 2020): 170–76. http://dx.doi.org/10.1177/1757177420921916.
Повний текст джерелаTonouchi, Keisuke, Yu Adachi, Saya Moriyama, Kaori Sano, Koshiro Tabata, Keigo Ide, Haruko Takeyama, Tadaki Suzuki, and Yoshimasa Takahashi. "Stereotyped B-cell response that counteracts antigenic variation of influenza viruses." International Immunology 32, no. 9 (June 6, 2020): 613–21. http://dx.doi.org/10.1093/intimm/dxaa038.
Повний текст джерелаKogure, Toshiaki, Naoyuki Harada, Yuko Oku, Takeshi Tatsumi, and Atsushi Niizawa. "The Observation of Humoral Responses after Influenza Vaccination in Patients with Rheumatoid Arthritis Treated with Japanese Oriental (Kampo) Medicine: An Observational Study." Evidence-Based Complementary and Alternative Medicine 2012 (2012): 1–6. http://dx.doi.org/10.1155/2012/320542.
Повний текст джерелаAjejas Bazán, María Julia, Ramón Del Gallego-Lastra, Cristina Maria Alves Marques-Vieira, Candelas López-López, Silvia Domínguez-Fernández, Milagros Rico-Blázquez, and Francisco Javier Pérez-Rivas. "Vaccine Coverage against Influenza and SARS-CoV-2 in Health Sciences Students during COVID-19 Pandemic in Spain." Vaccines 10, no. 2 (January 21, 2022): 159. http://dx.doi.org/10.3390/vaccines10020159.
Повний текст джерелаGRAN, J. M., B. IVERSEN, O. HUNGNES, and O. O. AALEN. "Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975–2004." Epidemiology and Infection 138, no. 11 (March 25, 2010): 1559–68. http://dx.doi.org/10.1017/s0950268810000671.
Повний текст джерелаTarrasa, Giancarlo Hernán Cristerna, Martha Ramiro Mendoza, Francisco Javier Otero Mendoza, and Eduardo Arias de la Garza. "#29: Clinical Evaluation of Pediatric Patients with Respiratory Symptoms with Confirmed and Negative Influenza in a Third-level Pediatric Center in Mexico City." Journal of the Pediatric Infectious Diseases Society 10, Supplement_1 (March 1, 2021): S23—S24. http://dx.doi.org/10.1093/jpids/piaa170.075.
Повний текст джерелаHu, Zenglei, Ya Huang, Jiangyan Zhao, Jiao Hu, Shunlin Hu, and Xiufan Liu. "Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses." Protein Expression and Purification 192 (April 2022): 106046. http://dx.doi.org/10.1016/j.pep.2022.106046.
Повний текст джерелаLi, Zhanping, Zhimin Wan, Tuofan Li, Quan Xie, Haiwei Sun, Hongjun Chen, Guangchen Liang, Hongxia Shao, Aijian Qin, and Jianqiang Ye. "A novel linear epitope crossing Group 1 and Group 2 influenza A viruses located in the helix A of HA2 derived from H7N9." Veterinary Microbiology 228 (January 2019): 39–44. http://dx.doi.org/10.1016/j.vetmic.2018.11.002.
Повний текст джерелаKordyukova, Larisa V., Marina V. Serebryakova, Anton A. Polyansky, Ekaterina A. Kropotkina, Andrei V. Alexeevski, Michael Veit, Roman G. Efremov, Irina Yu Filippova, and Lyudmila A. Baratova. "Linker and/or transmembrane regions of influenza A/Group-1, A/Group-2, and type B virus hemagglutinins are packed differently within trimers." Biochimica et Biophysica Acta (BBA) - Biomembranes 1808, no. 7 (July 2011): 1843–54. http://dx.doi.org/10.1016/j.bbamem.2011.03.005.
Повний текст джерелаProkopeva, E. A., K. A. Sharshov, A. A. Romanovskaya, I. A. Sobolev, O. G. Kurskaya, E. I. Soloveva, L. V. Shestopalova, A. V. Zaykovskaya, A. Yu Alekseev, and A. M. Shestopalov. "COMPARATIVE ANALYSIS OF PATHOGENICITY OF INFLUENZA A(H5N1) AND A(H1N1)pdm09 VIRUSES IN MICE." Journal of microbiology epidemiology immunobiology, no. 2 (April 28, 2018): 38–44. http://dx.doi.org/10.36233/0372-9311-2018-2-38-44.
Повний текст джерелаGittelman, Rachel M., Erik Yusko, Catherine M. Sanders, Marissa Vignali, Adrian McDermott, and Harlan Robins. "Detection and tracking of public, broadly neutralizing antibodies against group 1 and group 2 Influenza A viruses in healthy donors and post-seasonal flu vaccine." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 73.4. http://dx.doi.org/10.4049/jimmunol.198.supp.73.4.
Повний текст джерелаWatanabe, Aripuanã Sakurada Aranha, Emerson Carraro, João Manuelo Grisi Candeias, Maria Rita Donalísio, Élcio Leal, Celso Francisco Hernandes Granato, and Nancy Bellei. "Viral etiology among the elderly presenting acute respiratory infection during the influenza season." Revista da Sociedade Brasileira de Medicina Tropical 44, no. 1 (February 2011): 18–21. http://dx.doi.org/10.1590/s0037-86822011000100005.
Повний текст джерелаAmmari, Tawfiq, Sangseok You, and Lionel P. Robert Jr. "Alternative Group Technologies and Their Influence on Group Technology Acceptance." American Journal of Information Systems 6, no. 2 (July 11, 2018): 29–37. http://dx.doi.org/10.12691/ajis-6-2-1.
Повний текст джерелаComeaux, Christy, Arangassery Rosemary Bastian, Els De Paepe, Edmund Omoruyi, Wouter Haazen, Hanneke Schuitemaker, Cynthia Strout, Benoit Callendret, and Jerald Sadoff. "2775. Safety and Immunogenicity of a Seasonal Influenza Vaccine and Ad26.RSV.preF Vaccine With and Without Co-Administration: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study in Adults Aged ≥ 60 Years." Open Forum Infectious Diseases 6, Supplement_2 (October 2019): S979. http://dx.doi.org/10.1093/ofid/ofz360.2452.
Повний текст джерелаPark, Jin Kyun, Min Ah Lee, Eun Young Lee, Yeong Wook Song, Yunhee Choi, Kevin L. Winthrop, and Eun Bong Lee. "Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial." Annals of the Rheumatic Diseases 76, no. 9 (May 3, 2017): 1559–65. http://dx.doi.org/10.1136/annrheumdis-2017-211128.
Повний текст джерелаPervoushina, Yu V., V. V. Gorbunov, and S. A. Lukyanov. "Cardiovascular complications in patients with severe pneumonia with influenza A/H1N1 / 09." Сибирский научный медицинский журнал 41, no. 4 (August 26, 2021): 54–57. http://dx.doi.org/10.18699/ssmj20210407.
Повний текст джерелаDerkach, Andrii. "Immune homeostasis of a woman after the influenza in early pregnancy." Perinatology and reproductology: from research to practice 2, no. 1 (April 7, 2022): 18–25. http://dx.doi.org/10.52705/2788-6190-2022-01-2.
Повний текст джерелаTataridis, Dimitrios, George Fytas, Antonios Kolocouris, Christos Fytas, Nicolas Kolocouris, George B. Foscolos, Elizaveta Padalko, Johan Neyts, and Erik De Clercq. "Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A." Bioorganic & Medicinal Chemistry Letters 17, no. 3 (February 2007): 692–96. http://dx.doi.org/10.1016/j.bmcl.2006.10.092.
Повний текст джерелаKang, Chang Kyung, Hang-Rae Kim, Kyoung-Ho Song, Bhumsuk Keam, Seong Jin Choi, Pyoeng Gyun Choe, Eu Suk Kim, et al. "Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors." Journal of Infectious Diseases 222, no. 11 (June 1, 2020): 1902–9. http://dx.doi.org/10.1093/infdis/jiaa291.
Повний текст джерелаGhandili, Susanne, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, and Franziska Modemann. "A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies." Blood 138, Supplement 1 (November 5, 2021): 2286. http://dx.doi.org/10.1182/blood-2021-147438.
Повний текст джерела